TRX 3
Alternative Names: TolerMab Anti-CD2 monoclonal antibody; TRX3; TRX3 antibody - TolerRxLatest Information Update: 01 Sep 2005
At a glance
- Originator TolerRx
- Class Antipsoriatics; Monoclonal antibodies
- Mechanism of Action Immunosuppressants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Psoriasis
Most Recent Events
- 01 Sep 2005 Discontinued - Preclinical for Psoriasis in USA (unspecified route)
- 05 Feb 2003 Preclinical trials in Psoriasis in USA (unspecified route)